Related News
Home » Business » Manufacturing
Abbott redefines responsibility for health care needs
IN its first citizenship report in China released today, pharmaceuticals and medical company Abbott redefined responsibility as: Protecting Patients and Consumers, Innovating for the Future, Enhancing Access and Safeguarding the Environment.
Abbott has won a series of awards for its efforts in social responsibility (citizenship) such as Dow Jones Sustainability World Index and North America Index's global leadership in economic, environmental and social performance, ranking 6th of "100 Best Corporate Citizens List 2010" by Corporate Responsibility magazine and FORTUNE magazine's No. 1 Most Admired Company in its industry sector in 2010, said in its citizenship report.
The report with the title "Redefining Responsibility" is available online at www.abbott.com.cn and www.abbott.com/citizenship.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.
Abbott has been operating in China for nearly 20 years and provides Chinese consumers with a diverse range of nutrition, pharmaceutical and medical products. Opening in 2009, Abbott invested approximately US$20 million in a new nutritional manufacturing facility in Guangzhou. Abbott has more than 3,000 employees in China.
Abbott has won a series of awards for its efforts in social responsibility (citizenship) such as Dow Jones Sustainability World Index and North America Index's global leadership in economic, environmental and social performance, ranking 6th of "100 Best Corporate Citizens List 2010" by Corporate Responsibility magazine and FORTUNE magazine's No. 1 Most Admired Company in its industry sector in 2010, said in its citizenship report.
The report with the title "Redefining Responsibility" is available online at www.abbott.com.cn and www.abbott.com/citizenship.
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.
Abbott has been operating in China for nearly 20 years and provides Chinese consumers with a diverse range of nutrition, pharmaceutical and medical products. Opening in 2009, Abbott invested approximately US$20 million in a new nutritional manufacturing facility in Guangzhou. Abbott has more than 3,000 employees in China.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.